Original Source(s)
Related Content
FDA Monthly Preview: Key May Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
April 29, 2026
-
4 min
Recognizing MacTel Masquerades
Imaging features such as retinal thinning and ellipsoid zone loss can help differentiate MacTel from AMD and related retinal diseases.
May 14, 2026
-
2 min
Vamikibart Shows Early Safety in Uveitic Macular Edema
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
-
3 min
